MRI of the Chest Under High Frequency Ventilation

Status Completed

Clinical Trial Summary

The purpose of the study is to evaluate the benefit on image quality of MRI of the chest performed under high frequency non-invasive ventilation. This technique indeed allows to generate an apnea duration of several minutes with acquisitions performed at full inspiration. This study will be applied on healthy subjects.

Clinical Trial Description

High frequency ventilation (HF-V) has been applied by using a non-invasive interface allowing to obtain a prolonged apnea in awaken subjects. Such an application should be of interest for MRI taking into account its susceptibility to motion of the chest and the imperfect techniques of respiratory gating that are usually performed at end expiration. The purpose of this study is to assess the benefit on image quality of different sequences performed with and without the device in healthy subjects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02973373
Study type	Interventional
Source	University of Lausanne Hospitals
Contact
Status	Completed
Phase	N/A
Start date	November 2016
Completion date	July 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06326723` - Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects	Phase 1
Recruiting	`NCT00001367` - Diagnosis and History Study of Patients With Different Neurological Conditions
Completed	`NCT02699710` - Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects	Phase 1
Completed	`NCT02231892` - Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study	N/A
Not yet recruiting	`NCT06441916` - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions	Phase 1
Completed	`NCT03771586` - A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects	Phase 1
Not yet recruiting	`NCT06337422` - Bioequivalence Study of Generic Celecoxib 200 mg Capsules	Phase 1
Completed	`NCT03302182` - Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects	Phase 1
Completed	`NCT05049343` - Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants	Phase 1
Recruiting	`NCT01629108` - Normal Values in Hearing and Balance Testing
Completed	`NCT02947854` - Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant	Phase 1
Completed	`NCT02534870` - Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects	Phase 1
Completed	`NCT02224053` - Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers	Phase 1
Completed	`NCT01711762` - A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers	Phase 1
Completed	`NCT01684891` - A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers	Phase 1
Completed	`NCT01697436` - A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets	Phase 1
Completed	`NCT01676584` - A Study of Single Dose RO6811135 in Healthy Volunteers	Phase 1
Completed	`NCT01461967` - A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers	Phase 1
Completed	`NCT01414881` - Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects	Phase 1
Completed	`NCT01579149` - A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent	Phase 1